Sort
4,870 grants matching “glp 1”
A novel therapy for acute alcoholic hepatitis
$358,239Neil McDonnell · Seal Rock Therapeutics, Inc. · R43 · FY2022 · AA
PCAF/GCN5 Acetylation on p53 Transactivation
$358,126Shelley L Berger · University Of Pennsylvania · R01 · FY2010 · CA
Mechanotransduction in gastrointestinal physiology
$357,750Arthur Beyder · Mayo Clinic Rochester · R01 · FY2022 · DK
Mechanotransduction in gastrointestinal physiology
$357,750Arthur Beyder · Mayo Clinic Rochester · R01 · FY2023 · DK
Mechanotransduction in gastrointestinal physiology
$357,750Arthur Beyder · Mayo Clinic Rochester · R01 · FY2019 · DK
Mechanotransduction in gastrointestinal physiology
$357,750Arthur Beyder · Mayo Clinic Rochester · R01 · FY2021 · DK
Mechanotransduction in gastrointestinal physiology
$357,750Arthur Beyder · Mayo Clinic Rochester · R01 · FY2020 · DK
Dose-ranging safety and efficacy studies to advance novel mechanism-of-action drug candidates to reverse age-related muscle degeneration
$357,630Stanley Watowich · Ridgeline Therapeutics, Llc · R41 · FY2018 · AG
Development of a therapeutic Kv7 opener to restore motor excitability in ALS
$357,589Sandy Hinckley · Quralis Corporation · R44 · FY2020 · NS
Dissecting mechanisms of GLP-1 based therapies for Type II Diabetes
$357,511Randy J. Seeley · University Of Cincinnati · R01 · FY2013 · DK
Repositioning Gliptins for Parkinson's Disease Treatment
$357,406Barry J Hoffer · Case Western Reserve University · R01 · FY2015 · NS
Novel Agonists and Inverse Agonists for B-Family GPCRs
$357,321Samuel H. Gellman · University Of Wisconsin-Madison · R01 · FY2023 · GM
Novel Agonists and Inverse Agonists for B-Family GPCRs
$357,321Samuel H. Gellman · University Of Wisconsin-Madison · R01 · FY2022 · GM
Predictors of Weight Loss and Weight Loss Maintenance to Lifestyle Modification Therapy and Pharmacotherapy for Adolescents with Obesity
$357,024Amy C. Gross · University Of Minnesota · R01 · FY2024 · DK
Pharmaceutical and Regulatory Core
$356,796David R Friend · Magee-Women'S Res Inst And Foundation · U19 · FY2010 · AI
cAMP signaling in the pancreatic B cell
$356,625University Of Pennsylvania · R21 · FY2003 · DK
cAMP signaling in the pancreatic B cell
$356,625University Of Pennsylvania · R21 · FY2002 · DK
Scale-up and Manufacturing of STLR-201, an off-the-shelf regenerative therapeutic for Sjogren's syndrome-related dry eye disease
$356,485Bradford Dykstra · Stellular Bio, Inc. · R44 · FY2025 · EY
The role of central GLP-1 receptors in animal models of cocaine addiction
$356,400Heath D Schmidt · University Of Pennsylvania · R01 · FY2016 · DA
Targeting Estrogen Receptors to Protect Functional Beta-cell Mass in Diabetes
$356,123Franck Mauvais-Jarvis · Northwestern University At Chicago · R01 · FY2012 · DK
Glomerular and Tubular Function in the Diabetic Kidney
$355,924Scott C. Thomson · Veterans Medical Research Fdn/San Diego · R01 · FY2014 · DK
Drug Development of GLP-1 receptor agonists
$355,505Josephine Egan · National Institute On Aging · ZIA · FY2011 · AG
GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV (GL1DER HIV RCT)
$355,050Hilary A. Tindle · Vanderbilt University Medical Center · P60 · FY2025 · AA
PCAF/GCN5 Acetylation on p53 Transactivation
$354,807Shelley L Berger · University Of Pennsylvania · R01 · FY2009 · CA
Stress, Appetite, and Smoking Relapse
$354,775Mustafa N Al'absi · University Of Minnesota · R01 · FY2010 · DA